Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 22

Sort by

Sort Order Select

Journal Articles

Perioperative Eltrombopag or Intravenous Immune Globulin for Patients with Immune Thrombocytopenia: A Multicenter Randomized Trial

Donald M. Arnold, MD, Nancy Heddle, MSc, Richard Cook, Cyrus C. Hsia, MDBSc,FRCPC, Mark Blostein, MDFRCPC, Erin Jamula, MSc, Michelle Sholzberg, MDBSc,FRCPC,MSc, Yulia Lin, MD, Jeannine Kassis, MD, Loree Larratt, MD FRCP(C), Sufia Amini, MD, Martin R. Schipperus, Wendy Lim, MD MSc, Prakash Vishnu, MD, Margaret Warner, FRCPC, Julie Carruthers, MLT, B.Com(Hon), Shannon J Lane, MPH, Na Li, PhD, John G. Kelton, MD

Blood (2019) 134 (Supplement_1): 896.

https://doi.org/10.1182/blood-2019-122609

Published: 2019

Journal Articles

Identification of a Novel Heterozygous Mutation ( c.2213T>G;p.Leu738Arg ) in Platelet Glycoprotein ITGB3 gene in a Patient with Glanzmann's Thrombasthenia

Candido E. Rivera, MD, Prakash Vishnu, MD, Gretchen Schaef Johns, MD, Rajiv K. Pruthi, M.B.B.S., Dong Chen, MD PhD

Blood (2018) 132 (Supplement 1): 1158.

https://doi.org/10.1182/blood-2018-99-117995

Published: 2018

Journal Articles

Timeliness of Initial Therapy in Multiple Myeloma (MM): Trends and Factors Influencing Patient Care

Vivek Kumar, MD, M.B.,B.S., Taimur Sher, MD, Leyla Bojanini, MD, Prakash Vishnu, MD, Vivek Roy, MD, Rami Manochakian, MD, Sri Lekha Bodepudi, Zan Tahir Shareef, Salman Ahmed, MD, Prachi Jani, MD, Victoria R. Alegria, Meghna Ailawadhi, MD, Aneel Paulus, MD, Sonikpreet Aulakh, MD, Madiha Iqbal, MBBS, Asher A. Chanan-Khan, MD, Sikander Ailawadhi

Blood (2018) 132 (Supplement 1): 4764.

https://doi.org/10.1182/blood-2018-99-120127

Published: 2018

Journal Articles

Trends in the Utilization of Radiation Therapy (XRT) Among Patients with Non-Hodgkin's Lymphoma (NHL) in the United States (US)

Vivek Kumar, MD, M.B.,B.S., Taimur Sher, MD, Prakash Vishnu, MD, Vivek Roy, MD, Anne M Hazen, A.R.N.P.,M.S.N, Victoria R. Alegria, Meghna Ailawadhi, MD, Salman Ahmed, MD, Prachi Jani, MD, Zan Tahir Shareef, Sri Lekha Bodepudi, Aneel Paulus, MD, Asher A. Chanan-Khan, MD, Sikander Ailawadhi

Blood (2018) 132 (Supplement 1): 4765.

https://doi.org/10.1182/blood-2018-99-119981

Published: 2018

Journal Articles

Disparity in Clinical Trial Opportunities for Patients with B-Cell Malignancies in the United States

Sikander Ailawadhi, Sri Lekha Bodepudi, Zan Tahir Shareef, Fabiola Coromoto Cardozo, Salman Ahmed, MD, Prachi Jani, MD, Shishir David, Vivek Roy, MD, Aneel Paulus, MD, Victoria R. Alegria, Vivek Kumar, MD, M.B.,B.S., Meghna Ailawadhi, MD, Prakash Vishnu, MD, Sonikpreet Aulakh, MD, Rami Manochakian, MD, Asher A. Chanan-Khan, MD, Taimur Sher, MD

Blood (2018) 132 (Supplement 1): 4861.

https://doi.org/10.1182/blood-2018-99-117155

Published: 2018

Journal Articles

Trends in the Risk of Second Primary Malignancies (SPMs) Among Survivors of Chronic Lymphocytic Leukemia(CLL)

Vivek Kumar, MD, M.B.,B.S., Sikander Ailawadhi, Leyla Bojanini, MD, Aditya Mehta, Anshika Singh, Taimur Sher, MD, Vivek Roy, MD, Prakash Vishnu, MD, Julian A Marin-Acevedo, Victoria R. Alegria, Aneel Paulus, MD, Sonikpreet Aulakh, MD, Madiha Iqbal, MBBS, Rami Manochakian, MD, Winston Tan, MD, Asher A. Chanan-Khan, MD, Meghna Ailawadhi, MD

Blood (2018) 132 (Supplement 1): 4869.

https://doi.org/10.1182/blood-2018-99-116361

Published: 2018

Journal Articles

Quality Initiative in Clinical Practice: A Single Institution Appraisal of Quality Metrics in the Management of Newly Diagnosed Diffuse Large B-Cell Lymphoma Based on the American Society of Hematology Practice Improvement Module

Alina Bischin, BA, David M. Aboulafia, MD, Prakash Vishnu, MD, Kevin Knopf, MD, Ruqin Chen, MD

Blood (2018) 132 (Supplement 1): 4781.

https://doi.org/10.1182/blood-2018-99-115207

Published: 2018

Journal Articles

Sociodemographic Profile and Outcomes of Patients with Non-Diffuse Large B-Cell Lymphoma (non-DLBCL) Treated at Minority-Predominant Facilities in the United States

Vivek Kumar, MD, M.B.,B.S., Taimur Sher, MD, Vivek Roy, MD, Prakash Vishnu, MD, Anne M Hazen, A.R.N.P.,M.S.N, Victoria R. Alegria, Meghna Ailawadhi, MD, Sri Lekha Bodepudi, Zan Tahir Shareef, Fabiola Coromoto Cardozo, Salman Ahmed, MD, Prachi Jani, MD, Aneel Paulus, MD, Asher A. Chanan-Khan, MD, Sikander Ailawadhi

Blood (2018) 132 (Supplement 1): 4868.

https://doi.org/10.1182/blood-2018-99-119976

Published: 2018

Journal Articles

Exploring Disease Biology in Hispanic Versus Non-Hispanic Patients with Diffuse Large B-Cell Lymphoma (DLBCL) to Explain Survival Disparities

Sikander Ailawadhi, Alvaro J. Alencar, MD, Madiha Iqbal, MBBS, Prachi Jani, MD, Salman Ahmed, MD, Aditya Mehta, Ruqin Chen, MD, Leyla Bojanini, MD, Moises Harari Turquie, MD, Kevin R Kelly, MD PhD, Prakash Vishnu, MD, Vivek Roy, MD, Anshika Singh, Abuzar Asif, Shishir David, Imran Siddiqi, MD PhD, Asher A. Chanan-Khan, MD, Taimur Sher, MD

Blood (2018) 132 (Supplement 1): 4867.

https://doi.org/10.1182/blood-2018-99-119494

Published: 2018

Journal Articles

Decreased Physical Activity in Autologous Stem Cell Recipients Leads to Reduced QOL Scores during Hospitalization

Candice Baldeo, MBBS, Yenny Moreno Vanegas, MD, Sharad Khurana, MBBS, Madiha Iqbal, MBBS, Abdel-Ghani Azzouqa, MD, Taimur Sher, MD, Sikander Ailawadhi, Prakash Vishnu, MD

Blood (2018) 132 (Supplement 1): 5895.

https://doi.org/10.1182/blood-2018-99-112149

Published: 2018

Journal Articles

Clinical Outcomes and Cost Analysis of Dose-Adjusted R-EPOCH Vs R-CHOP in Treatment of Diffuse Large B- Cell Lymphoma with High Risk Features

Bhagirathbhai Dholaria, MBBS, Prakash Vishnu, MD, Yenni Alejandro Moreno-Vanegas, Aaron C. Spaulding, Nancy N. Diehl, David Hodge, Candido E. Rivera, MD, Han Tun, MD

Blood (2018) 132 (Supplement 1): 4790.

https://doi.org/10.1182/blood-2018-99-117743

Published: 2018

Journal Articles

Utilization of Radiation Therapy in Multiple Myeloma: Trends and Changes in Practice

Sikander Ailawadhi, Ryan D. Frank, Zahara Meghji, Prachi Jani, MD, Raj Patel, MD, Mark A. Fiala, BS, Tanya S. Kakar, Sonikpreet Aulakh, MD, Ankita Aggarwal, David O. Hodge, MS, Taimur Sher, MD, Vivek Roy, MD, Meghna Ailawadhi, MD, Victoria R. Alegria, Prakash Vishnu, MD FACP, Aneel Paulus, MD, Asher A. Chanan-Khan, MD

Blood (2017) 130 (Supplement 1): 3395.

https://doi.org/10.1182/blood.V130.Suppl_1.3395.3395

Published: 2017

Journal Articles

Guidelines in Clinical Practice: Appraisal of Quality Metrics in the Management of Newly Diagnosed Diffuse Large B-Cell Lymphoma Based on the American Society of Hematology Practice Improvement Module

Alina Bishin, Prakash Vishnu, MD FACP, Margaret Mandelson, David M. Aboulafia, MD

Blood (2017) 130 (Supplement 1): 5613.

https://doi.org/10.1182/blood.V130.Suppl_1.5613.5613

Published: 2017

Journal Articles

Extreme Thrombocytosis: Influence of Care Setting and Likelihood of Occult Malignancy

Ronan W. Hsieh, MD, Aishwarya Ravindran, MBBS, C. Christopher Hook, MD, Rajiv K. Pruthi, MBBS, Ariela L. Marshall, MD, Aneel A. Ashrani, MD, Kebede H. Begna, MD, Timothy G. Call, MD, William J. Hogan, MBBCh, Mark R. Litzow, MD, James D. Hoyer, MD, Jennifer L. Oliveira, MD, Prakash Vishnu, MD FACP, Ayalew Tefferi, MD, Michelle A. Elliott, MD, Aref Al-Kali, MD, Alexandra P. Wolanskyj-Spinner, MD, Ronald S. Go, MD

Blood (2017) 130 (Supplement 1): 1644.

https://doi.org/10.1182/blood.V130.Suppl_1.1644.1644

Published: 2017

Journal Articles

Utilization of Palliative Care Among Patients with Hematologic Malignancies: An Extensive National Analysis to Define Trends and Patterns

Sikander Ailawadhi, Ryan D. Frank, Nicolette T. Chimato, Prachi Jani, MD, Aaron C. Spaulding, Mark A. Fiala, BS, Judith Kaur, MD, David O. Hodge, MS, Taimur Sher, MD, Vivek Roy, MD, Prakash Vishnu, MD FACP, Meghna Ailawadhi, MD, Victoria R. Alegria, Aneel Paulus, MD, Asher A. Chanan-Khan, MD, Dorin T. Colibaseanu, MD

Blood (2017) 130 (Supplement 1): 2107.

https://doi.org/10.1182/blood.V130.Suppl_1.2107.2107

Published: 2017

Journal Articles

Factors Determining Utilization of Stem Cell Transplant (SCT) for Initial Therapy of Multiple Myeloma (MM) By Patient Race: Exploring Intra-Racial Healthcare Disparities

Sikander Ailawadhi, Ryan D. Frank, Nicolette T. Chimato, Zahara Meghji, Raj Patel, MD, Prachi Jani, MD, Tanya S. Kakar, Mark A. Fiala, BS, Sonikpreet Aulakh, MD, David O. Hodge, MS, Taimur Sher, MD, Vivek Roy, MD, Prakash Vishnu, MD FACP, Meghna Ailawadhi, MD, Victoria R. Alegria, Aneel Paulus, MD, Asher A. Chanan-Khan, MD

Blood (2017) 130 (Supplement 1): 860.

https://doi.org/10.1182/blood.V130.Suppl_1.860.860

Published: 2017

Journal Articles

DA.R-EPOCH Vs. R-CHOP for High-Risk Diffuse Large B- Cell Lymphoma: The Mayo Clinic Florida Experience

Bhagirathbhai Dholaria, MBBS, Prakash Vishnu, MD FACP, Vivek Roy, MD, Han W Tun, MD, Taimur Sher, MD, Candido E. Rivera, MD, Sikander Ailawadhi, Nancy Diehl, David O. Hodge, MS, Yenni Alejandro Moreno-Vanegas

Blood (2017) 130 (Supplement 1): 1572.

https://doi.org/10.1182/blood.V130.Suppl_1.1572.1572

Published: 2017

Journal Articles

Splenectomy or Rituximab in Steroid-Refractory Immune Thrombocytopenia (ITP): The Mayo Clinic Experience

William A. Hammond, MD, Elisa M. Rodriguez, Zhuo Li, M.S, Bhagirathbhai Dholaria, MBBS, Amanda Shreders, MD, Prakash Vishnu, MD, Candido E. Rivera, MD

Blood (2016) 128 (22): 3735.

https://doi.org/10.1182/blood.V128.22.3735.3735

Published: 2016

Journal Articles

[ 18 f]PET-CT Scan Is Highly Accurate in Identifying Marrow Involvement of Diffuse Large B-Cell Lymphoma

Prakash Vishnu, MD FACP, Andrew Wingerson, Marie Lee, MD, Margaret Mandelson, David M Aboulafia, MD

Blood (2016) 128 (22): 2355.

https://doi.org/10.1182/blood.V128.22.2355.2355

Published: 2016

Journal Articles

Utility of Bone Marrow Biopsy in the Staging of Diffuse Large B-Cell Lymphoma in the Era of PET-CT

Prakash Vishnu, MD FACP, Andrew Wingerson, David M Aboulafia, MD

Blood (2015) 126 (23): 5637.

https://doi.org/10.1182/blood.V126.23.5637.5637

Published: 2015

NARROW

Perioperative Eltrombopag or Intravenous Immune Globulin for Patients with Immune Thrombocytopenia: A Multicenter Randomized Trial

Identification of a Novel Heterozygous Mutation ( c.2213T>G;p.Leu738Arg ) in Platelet Glycoprotein ITGB3 gene in a Patient with Glanzmann's Thrombasthenia

Timeliness of Initial Therapy in Multiple Myeloma (MM): Trends and Factors Influencing Patient Care

Trends in the Utilization of Radiation Therapy (XRT) Among Patients with Non-Hodgkin's Lymphoma (NHL) in the United States (US)

Disparity in Clinical Trial Opportunities for Patients with B-Cell Malignancies in the United States

Trends in the Risk of Second Primary Malignancies (SPMs) Among Survivors of Chronic Lymphocytic Leukemia(CLL)

Quality Initiative in Clinical Practice: A Single Institution Appraisal of Quality Metrics in the Management of Newly Diagnosed Diffuse Large B-Cell Lymphoma Based on the American Society of Hematology Practice Improvement Module

Sociodemographic Profile and Outcomes of Patients with Non-Diffuse Large B-Cell Lymphoma (non-DLBCL) Treated at Minority-Predominant Facilities in the United States

Exploring Disease Biology in Hispanic Versus Non-Hispanic Patients with Diffuse Large B-Cell Lymphoma (DLBCL) to Explain Survival Disparities

Decreased Physical Activity in Autologous Stem Cell Recipients Leads to Reduced QOL Scores during Hospitalization

Clinical Outcomes and Cost Analysis of Dose-Adjusted R-EPOCH Vs R-CHOP in Treatment of Diffuse Large B- Cell Lymphoma with High Risk Features

Utilization of Radiation Therapy in Multiple Myeloma: Trends and Changes in Practice

Guidelines in Clinical Practice: Appraisal of Quality Metrics in the Management of Newly Diagnosed Diffuse Large B-Cell Lymphoma Based on the American Society of Hematology Practice Improvement Module

Extreme Thrombocytosis: Influence of Care Setting and Likelihood of Occult Malignancy

Utilization of Palliative Care Among Patients with Hematologic Malignancies: An Extensive National Analysis to Define Trends and Patterns

Factors Determining Utilization of Stem Cell Transplant (SCT) for Initial Therapy of Multiple Myeloma (MM) By Patient Race: Exploring Intra-Racial Healthcare Disparities

DA.R-EPOCH Vs. R-CHOP for High-Risk Diffuse Large B- Cell Lymphoma: The Mayo Clinic Florida Experience

Splenectomy or Rituximab in Steroid-Refractory Immune Thrombocytopenia (ITP): The Mayo Clinic Experience

[ 18 f]PET-CT Scan Is Highly Accurate in Identifying Marrow Involvement of Diffuse Large B-Cell Lymphoma

Utility of Bone Marrow Biopsy in the Staging of Diffuse Large B-Cell Lymphoma in the Era of PET-CT

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only